|
|
||||||||




* The Wistar Institute, Philadelphia, PA 19104;
Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, PA 19122; and
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104
Autoreactive B cells may become activated in a T-independent manner via synergistic engagement of the BCR and TLRs. Using the VH3H9 Ig H chain transgene to track anti-chromatin B cells, we demonstrate that VH3H9/V
1 anti-chromatin B cells proliferate in response to stimulatory oligodeoxynucleotides containing CpG motifs, suggesting that these autoreactive B cells are responsive to TLR9 signaling. Strikingly, some VH3H9 B cells, but not the well-characterized VH3H9/V
1 B cells, proliferate spontaneously in culture medium. This proliferation is blocked by inhibitory CpG oligodeoxynucleotides, implicating the TLR9 (or possibly TLR7) pathway. Most hybridomas generated from the proliferating cells are polyreactive, and one exhibits binding to nuclear Ags but not to the other Ags tested. Thus, B cells carrying autoreactive and/or polyreactive specificities may be susceptible to T cell-independent activation via dual engagement of the BCR and TLRs.
This article has been cited by other articles:
![]() |
F. Coffey, X. Liu, and T. Manser Primary Development and Participation in a Foreign Antigen-Driven Immune Response of a Chromatin-Reactive B Cell Clonotype Are Not Influenced by TLR9 or Other MyD88-Dependent TLRs J. Immunol., November 15, 2007; 179(10): 6663 - 6672. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Deane and S. Bolland Nucleic Acid-Sensing TLRs as Modifiers of Autoimmunity J. Immunol., November 15, 2006; 177(10): 6573 - 6578. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ma, F. Chen, M. P. Madaio, P. L. Cohen, and R. A. Eisenberg Modulation of Autoimmunity by TLR9 in the Chronic Graft-vs-Host Model of Systemic Lupus Erythematosus J. Immunol., November 15, 2006; 177(10): 7444 - 7450. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |